Ramaphosa accuses Big Pharma of 'selfish, unjust' vaccine policy

accreditation
0:00
play article
Subscribers can listen to this article
Ramaphosa lambasted a resistance to calls by India and South Africa for temporary patent waivers to ramp up production. (Getty Images)
Ramaphosa lambasted a resistance to calls by India and South Africa for temporary patent waivers to ramp up production. (Getty Images)

President Cyril Ramaphosa said on Monday the "selfish, unjust" refusal of pharmaceutical companies and allied Western governments to entertain emergency patent waivers on Covid-19 vaccines was endangering the entire world.

In unusually impassioned remarks, Ramaphosa lambasted a resistance to calls by India and South Africa for temporary patent waivers to ramp up production.

"It is selfish, it is unjust, it is wholly unfair," Ramaphosa, proponent of the waiver, told the opening virtual session of the Qatar Economic Forum, a day after South Africa registered 13 000 new cases in a third Covid-19 wave.

"We are facing an emergency that is affecting the entire world ... and some countries are refusing this provision to be waived," he said.

The proposed waiver from the WTO's agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) has support in principle from US President Joe Biden and French President Emmanuel Macron.

But the pharmaceutical industry is against the waiver, as are Germany, Switzerland and the World Bank. They argue it would stifle innovation and that vaccine supplies are constrained by a lack of manufacturing capacity.

Both India and South Africa say they have ample capacity.

"All we are asking is ... a three-year period to enable countries that have the capability to be able to produce the vaccines," Ramaphosa said. "Because no one is safe anywhere in the world without everyone being safe."

South Africa has only vaccinated about two million people, 1.8% of its population, one of the world's lowest rates.

It suffered a setback when Aspen Pharmacare (APNJ.J), local producer of the Johnson & Johnson vaccine, had to destroy two million doses due to contamination at a plant in Baltimore, Maryland, US. J&J is sending two million replacement doses.

Despite that setback, Ramaphosa said the government would stick with J&J because it is a one-shot vaccine, logistically a lot easier to manage in remote rural areas.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Rand - Dollar
17.99
+0.1%
Rand - Pound
20.13
-0.2%
Rand - Euro
17.65
-0.1%
Rand - Aus dollar
11.55
-0.0%
Rand - Yen
0.12
-0.2%
Gold
1,711.80
-0.1%
Silver
20.75
+0.4%
Palladium
2,255.50
-0.3%
Platinum
932.50
+0.8%
Brent Crude
94.42
+1.1%
Top 40
59,198
-0.4%
All Share
65,573
-0.4%
Resource 10
63,523
+0.4%
Industrial 25
79,396
-0.8%
Financial 15
13,959
-0.3%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE
Government tenders

Find public sector tender opportunities in South Africa here.

Government tenders
This portal provides access to information on all tenders made by all public sector organisations in all spheres of government.
Browse tenders